Fuel Multichannel Strategy: End-to-end content delivery Posted on June 16, 2023November 15, 2024 by Andrii Nikulin Do any of these questions sound familiar? How fast can I get a new presentation for eDetailing? What’s the best way to localize these assets for that new market? HCPs prefer online meetings, where to get content for remote calls? Will I launch this new email campaign on time? Is it possible to think creatively under such pressure? There are answers! Download free eBook and learn more about a unique approach. Get ready to supply multichannel content in a fast and easy way, enabling the most inspired and ambitious of marketing strategies.
Digital Content Factory: Strategic Approach to Digital Leadership Posted on June 16, 2023November 15, 2024 by Andrii Nikulin Your strategy will never be the same. An answer to the most relevant questions on digital excellence, this eBook demonstrates a unique solution for managing pharma digital content. The Digital Content Factory by Viseven Group is a concept based on the company’s experience with over 20 brands – an advanced method of collaboration between a global marketing team, local teams and external agencies. By creating a unified workspace for all these, you can effectively overcome the major obstacles to digital adoption and achieve a significant efficiency boost. Since about ¾ of commonly reported issues are linked to organizational patterns rather than technical difficulties, a more considerate approach to digital can solve them. You’ll learn about a completely new way to optimize budgets, align business processes and measure performance – all in a single amazing collection of tech ideas. Producing, managing and reusing content is now made easy for teams of marketers, even without specific programming skills. Unwrap the opportunities that come with advanced methods and win the digital marathon!
Potential and Challenges of the APAC Pharmaceutical Industry Posted on June 12, 2023November 15, 2024 by Andrii Nikulin The global pharmaceutical market is becoming more digitalized, insight-driven, and consumer-centric. Though we’re witnessing fundamental changes all over the world, each region has its peculiarities dictated by multiple local factors. In this article, we’ll focus on a pharmaceutical market in the APAC region, go through the differences between pharma in APAC and pharma in other parts of the world, and see the current state of the APAC pharma market. Main Potential of Pharma in the Asia-Pacific Region What role does the APAC region play in transforming today’s worldwide pharma market? This role is significant because the pharma market in APAC is increasing. According to one forecast, researchers anticipate that APAC pharma will grow 4.2% from 2022 to 2027. And it makes sense. With unique industry dynamics and fierce competition that impact innovation in each country of the APAC region, China and Japan remain the world’s second and third pharma markets after the US, with a value of $153 billion and $83 billion, respectively. As the world’s second largest pharma market, China remains the world’s largest producer of pharmaceutical ingredients despite several internal issues, such as pricing pressure, uncertain drug approval times, and the implementation of drug regulatory reforms. The most distinctive characteristic of pharma companies in APAC from pharma companies in the rest of the world is the domination in the clinical trials market. Surprisingly, nearly half of all clinical trials conducted in the world in 2021 had locations in APAC. As of 2022, APAC accounts for 57% of Phase I clinical trials and 49% of Phase II clinical trials worldwide. And surprisingly or not, the growth of APAC pharma and its potential for the global market lie in its challenges. APAC Pharma Challenges — The Viseven Event Summary, April 2023 Digital maturity, personalized customer engagement, and data-driven marketing have been accepted and implemented in Europe and the US for a few years. However, it’s not the case for most pharma companies in the Asia-Pacific region. APAC pharma companies have only recently started to adopt advanced ways of improving customer experience, optimizing marketing activities with data-driven methods, and streamlining supply chains. Viseven, a pharma MarTech company, attended three events in April 2023 to see how the pharma market in the APAC region is transforming. Here are the three different stories with perspectives from three specialists: Omnichannel is Yet to Come — The 6th China Digital Healthcare Innovation Summit Yanxia Tang, Account Executive at Viseven, visited the 6th China Digital Healthcare Innovation Summit in Shanghai on April 24-26, 2023. The China Digital Healthcare Innovation Summit is one of the most popular events for the medical and pharmaceutical industries in the APAC region. The senior-level executives of over 100 companies, including top players such as AstraZeneca, Bayer, Abbot, and Novartis, gathered to share digital transformation insights on medical services, marketing, omnichannel engagement, e-commerce, and other crucial topics. For Yanxia Tang, the 6th China Digital Healthcare Innovation Summit was very productive. She attended several panels, listened to the conference speakers, and met a few professionals from different companies. Specifically, she engaged with several important stakeholders and received valuable information about future sales and marketing strategies, decision-making vision, and innovation trends among Chinese pharmaceutical companies. “Omnichannel” is one of those new words many stakeholders at this summit heard of but still don’t exactly know what it means in terms of the transformation of healthcare and pharmaceuticals. I was there to provide insightful information on the latest trends in omnichannel marketing and explore novelties in the pharmaceutical industry,” says Yanxia Tang, Account Executive at Viseven. What’s Next for Customer Experience? — The MarTech Summit Singapore 2023 As one of the central hubs for technology and pharma companies, not only in APAC but in the world, Singapore is also a venue for multiple events dedicated to the evolution of digital marketing. On April 25-26, 2023, the Viseven team comprising Dodie Guadines, Viseven APAC Regional Director, and Nathaniel Manzano, Account Executive Lead, attended the MarTech Summit Singapore, a conference that hosted over 200 companies from multiple industries and markets like e-commerce, finance, consumer goods, electronics, and pharma. Dogie Guadines and Nathaniel Manzano considered the MarTech Summit Singapore 2023 a good place for gathering insights, networking, and contributing to the world of MarTech services. The attendees had an opportunity to choose from over 35 live sessions from more than 60 speakers. At the event, the representatives of companies with different goals and perspectives discovered the latest MarTech trends, learned more about data-driven marketing approaches, and shared their professional expertise. As one of the most promising providers of MarTech services for pharma and life sciences companies, Viseven couldn’t go amiss for the MarTech Summit Singapore. The Viseven team listened to the speakers who represented pharmaceutical companies at the conference: Miguel Rivera from Novartis — Customer Engagement and Experience Head, APAC & MEA Sebastien Boisseau from Menarini — Head of Customer Engagement, Digital Marketing & Innovation Gaurav Lalwani from GSK — Senior Director, Global Content & Marketing Operations “Our goal at the MarTech Summit Singapore 2023 was to understand what’s next for the MarTech industry as a whole. We identified upcoming trends in customer experience along explored business opportunities. We’re eager to build vital business relationships with other attendees. We have some arrangements we’ll be able to disclose soon,” says Dodie Guadines, Viseven APAC Regional Director. Personalized Communication — Korea Pharm & Bio 2023 Suyoung Kim, sales representative at Viseven, attended Korea Pharm & Bio 2023, a massive 4-day event dedicated to biopharmaceuticals, technology, pharma ingredients, health ingredients, smart healthcare, packaging, logistics, cosmetics, bioenvironmental laboratory, chemical machinery, outsourcing, and PR. At the 13th Korea International Pharmaceutical & Bio-Pharma Exhibition on April 18-21, attendees participated in over 100 seminars, conferences, and workshops. “I learned a lot about Korean medical companies and introduced Viseven to the conference attendees personally. The irony is that I was showing them how they can do the same job with their customers cheaper online,” says Suyoung Kim, Sales Representative at Viseven. Though South Korea is the third largest biopharma innovation hub, Suyoung admits that local pharma companies have low HCP engagement rates because marketers still use traditional methods of communication such as email, phone calls, and face-to-face visits. Suyoung went to the conference to share her insights on how pharma companies can switch from traditional communication to personalized customer journeys and increase brand awareness using solutions by Viseven.
Orphan disease awareness campaign Posted on May 26, 2023November 15, 2024 by Andrii Nikulin In Viseven company, one of our core values is to improve people’s lives. And today, we are proud to share the results of our latest collaboration on the project dedicated to the problem of orphan diseases in Ukraine. What are orphan diseases? Orphan diseases are conditions that occur extremely rarely – less than 1 case per 2000 of the country’s population. The vast majority of such diseases are genetically determined. Sometimes, orphan diseases might present symptoms that overlap with signs of many other conditions. This can cause long delays in making a correct and timely diagnosis. ⚕️ How can we overcome challenges in the diagnosis of orphan diseases in Ukraine? One of the ways to overcome the diagnosis challenges in Ukraine is to raise HCP awareness of orphan diseases, which was the main goal of our project. The project consisted of a close collaboration between Viseven and our customer – a global biopharmaceutical value-oriented company. We were able to successfully achieve this goal by pooling our resources and expertise in an omnichannel approach. What is the role of the omnichannel approach in this project? The project’s strategy was based on sending the target audience (HCPs of certain specialties who may encounter an orphan disease in their clinical practice) informative personalized communications. This communication consisted of approved Viber messages with information relevant to the HCP’s interests such as symptoms of the orphan disease they could encounter in their clinical practice. Communication contained brief information about the problem and a call to action to learn more by accessing a specialized site. We analyzed the results of each communication to understand the best approach for this audience and to refine the messaging. The omnichannel project is a “live” project, allowing us to change the content whenever necessary to keep HCPs engaged. What are the results at present? Our approach helped us maintain a stable read rate of over 55% through the entire campaign duration. This stable read rate indicated that more than half of the HCPs who received a Viber message from our campaign maintained their interest. We also sustained an average Click Rate of over 10%, which is a good sign that HCPs are interested in the topic. But what is most important is that we have “real-world” results: according to the data provided to us by our project partner, the number of referrals for genetic counseling of children with orphan disease signs has significantly increased. It means that our campaign has resulted in a tangible and significant increase in the level of awareness and vigilance of doctors regarding orphan diseases. ✔️ What is next? We are not going to stop here! Overall, we’re proud of what we’ve achieved with this awareness campaign and excited to see what the future brings for us. Together with our partner, we continue to work on this project by improving our communications with HCPs, developing new educational courses, and planning webinars and other activities. Our ultimate goal is to identify children with orphan diseases and allow them to receive treatment to improve their lives. And we will do everything in our power for this as this is not only our work – this is our core value.
How do mobile healthcare apps impact HCP and patient engagement? Posted on May 25, 2023November 15, 2024 by Andrii Nikulin Goal Mobile applications development for healthcare became one of the most promising trends in HCP engagement strategy. The demand for mHealth apps has become immense, as they have already established a new tone of connectivity in the HCPs-patients-pharma triangle and improved their collaboration. The current case study is focused on uncovering the potential of mobile health care applications, describing the extent and nature of their influence, and defining the future of mobile applications as a marketing tool, revolutionizing communication in the pharma industry. As well, we will talk about the potential of educational apps and how specialized mHealth apps are integrated into the omnichannel communication system. Challenges Understanding the real needs of the patients. Reaching higher personalization and transparency in mHealth apps. Increasing pharma brand awareness. Customer data acquisition and processing via mHealth apps. Solution Innovations in digital mHealth technologies help to augment clinical efficiency, provide accurate diagnosis and help pharma brands stand out. Also, mobile applications became an essential tool that helps to win over the patient’s and HCPs’ loyalty, provide real-time communication and, of course, increase the efficiency of your brand’s healthcare system. Impact The case study provides important insights into the role of mHealth applications in patient engagement and building sustained communication with HCPs. The study provides statistical data on patient and HCPs’ behavior, their preferences, and expectations considering mHealth applications and their features. Our expertise covers a wide range of mHealth apps development, where each kind of app is targeted to solve a specific challenge, such as: reaching a higher level of personalization, straightening patients’ awareness and adherence, or providing better education opportunities to field and sales forces. As well, the case study highlights the major app types, patient engagement apps, the scope of application, winning features, and the role of mobile applications in omnichannel communication. Fill out the form and download the “Mobile healthcare apps in HCP engagement and patient awareness” case study to learn more about mHealth opportunities and innovations.
Key Benefits of E-Detailing in Pharma Posted on May 15, 2023February 4, 2025 by Andrii Nikulin Pharmaceutical detailing is the most time-tested marketing format in the medical content world. Old-timer sales reps should remember how pharmaceutical companies reckoned face-to-face (F2F) visits with doctors as the most effective approach to achieving their sales targets. With the advent of digital marketing, plenty of new forms of online communication emerged and eventually superseded detailing, turning from the most fundamental method of engagement into one of many. But as it turned out, the power of engagement doesn’t depend on the number of sources. On the contrary, search engines and social media provided healthcare professionals (HCPs) with more information about products and trends in the pharmaceutical industry and made them fastidious. HCPs’ constantly increasing demand for personalized experiences encouraged pharma companies to refresh their marketing strategies and use pharmaceutical detailing in a new electronic way. After reading this guide, you’ll be able to define the main differences between detailing and e-detailing, discover the benefits of this content format in the context of innovation, and understand how to leverage its efficiency with other marketing channels. The guide will be equally helpful to experienced pharma representatives who want to revise their knowledge of detailing and specialists who joined the pharma sales force not long ago. Read it till the end to download a case study that contains professional content tips on presenting your pharma company and products with an engaging e-detailer. What Is Pharmaceutical Detailing? Pharmaceutical detailing is a marketing technique that allows sales representatives of a pharmaceutical company to promote products and services to healthcare professionals (HCPs) using a detailed presentation. Detailing plays a vital role in the pharmaceutical industry for many reasons. First, it helps build a strong relationship between pharmaceutical companies and healthcare professionals, providing the latter with detailed information on the latest research, new products, and so on. Pharmaceutical representatives who communicate with healthcare professionals serve as the main source of credible information, guiding them through all the available and new medications and educating them on how each can be incorporated into treatment plans. Moreover, detailing is a way for HCPs to stay current with the latest research and understand the direction of the pharmaceutical industry. With detailing, healthcare professionals can stay up to date with new findings and trends without spending much time learning more about the pharmaceutical landscape. Main Types of Detailing in the Pharmaceutical Industry There are several types of pharmaceutical detailing. Let’s look at some e-detailing examples and their importance. Academic detailing Academic detailing is a non-commercial face-to-face demonstration of new prescription drugs by healthcare professionals to their colleagues or patients in academic medical centers. Academic detailing has educational value. The goal of conducting academic detailing is to improve the quality and results of clinical trials, patient care, prescribing patterns, and prescribing behavior. Traditional detailing Traditional detailing is a face-to-face demonstration of pharmaceutical products and services by sales representatives to healthcare professionals. The goal of conducting detailing is to provide doctors with all the necessary information on new drugs and their effectiveness. E-Detailing E-detailing is a digital marketing practice used by pharmaceutical sales representatives to present a company’s products and services to healthcare professionals online with an interactive presentation called e-detailer. Depending on the marketing approach, some pharma marketing specialists divide e-detailing into two categories: self-detailing and remote detailing. In the process of self-detailing, an HCP reviews an e-detailer alone without the guidance of a pharmaceutical representative. Remote detailing is an online one-in-one demonstration of an e-detailer by a pharmaceutical representative to an HCP during a video call or webinar. There are also three types of e-detailing, subject to the purpose of HCP engagement. Benefits of E-Detailing for Pharmaceutical Sales Representatives According to a survey by BCG, 84% of physicians want to maintain or increase online interactions with pharmaceutical companies. Interestingly, the same report showed that 60% of HCPs prefer to learn more about new prescription products during an in-person visit by a pharmaceutical sales representative. In such a hybrid communication environment, detailing is a perfect way to engage with HCPs. Let’s find out why. Benefit 1. Full accessibility and increased engagement Typically, HCPs are very busy and don’t want to change their overloaded schedules or be interrupted because a sales rep needs to sell a new drug. E-detailers changed the way direct-to-consumer advertising works in the pharma industry. The high level of e-detailing accessibility multiplies the level of HCP engagement. E-detailing creates human-oriented experiences for HCPs, eliminating sales representative obtrusiveness that might have turned many health professionals off in the past. Now, it’s up to a health professional to decide how, where, and when to access information provided by pharmaceutical and life science companies. For some reason, an HCP can’t attend one-on-one meetings and can use an e-detailer anytime via any device they want, like a desktop computer, laptop, smartphone, or tablet, and via any preferred channel, such as email or social media. An HCP who doesn’t mind meeting with a sales rep can view an e-detailer during a video call or after a live webinar. Pharma sales reps can attract HCPs’ attention and create the feeling of total control over the situation thanks to e-detailing rich functionality: Media. Images, video, and audio help sales reps engage HCPs with an engaging story; Animation. Animated content looks way more attractive and engaging; Navigation Menu. HCPs can instantly jump to slides they like; References & Resources. All sources mentioned in an e-detailer are near at hand, which allows HCPs to check the authenticity of data presented in an e-detailer. Benefit 2. Detailed analytics One of the greatest benefits of electronic pharmaceutical detailing is that drug companies don’t have to meet HCPs personally to understand the overall impact of e-detailers on their decisions. Being integrated with in-depth analytics in a customer relationship management (CRM) system, an e-detailer contains key performance indicators (KPIs) to collect real-time data about HCPs’ interactions. There are several types of KPIs pharma companies can use: Quantitative KPIs: time per slide, the number of demonstrated slides, the order of slide demonstration, attitude towards the slide, and beyond; Qualitative KPIs: prescriptions, interactive surveys, and beyond. KPIs allow companies to track any HCPs’ actions on e-detailers depending on their business goals and the e-detailing pharma software they use. Performance metrics are crucial because they help sales representatives find and improve inefficiencies in their pharmaceutical detailing strategies. Benefit 3. HCP feedback and better customer experience Along with information received with performance metrics, direct feedback from health professionals can improve pharmaceutical detailing strategies and pharma marketing. One more slide with a simple feedback form added to the end of an e-detailer can dramatically increase customer experience in the future. By providing unique insights, HCPs can expand the knowledge of pharmaceutical companies about: The Subject of an E-Detailer. HCPs can share their professional and personal opinions on the brand, products, or any other e-detailing topic with a drug company; Quality of E-detailing. HCPs can recommend pharmaceutical representatives to improve the content and its appearance and find possible mistakes and inconsistencies; Target Audience. HCPs can tell about their colleges’ needs, preferences, interests, competence, expertise, and beyond; Pharma Industry and Market. Even if HCPs can say nothing about the industry and market, they may say something that would pull some suggestions out of the minds of pharmaceutical representatives. A pharma company can also create an interactive slide for conducting a survey based on multiple-choice questions as an alternative to a feedback form. In pharma marketing, such content has enormous potential for creating more effective means of HCP engagement. Benefit 4. Omnichannel versatility As one of the top healthcare marketing trends, omnichannel marketing is the future of communication between pharmaceutical representatives and HCPs. In an omnichannel environment, pharmaceutical companies combine e-detailing with other channels to create personalized customer journeys and engage with different groups of HCPs based on data analytics. To leverage the effectiveness of the e-detailing process for an HCP or a group of HCPs with the same characteristics, pharmaceutical sales representatives and marketers identify the most preferred combination of communication channels and use them as touchpoints in a customer journey at the right time. In such a way, e-detailing becomes human-centered, looks professional, and feels natural. E-Detailing Best Practices + Case Study There are several principal approaches to creating eDetailers your organization should consider. Be careful with texts Don’t overload the slides of your eDetailer with texts. The goal of any detailer is to support a sales representative’s pitch, not to be its basis. If an eDetailer contains too much text information, it could confuse an HCP. Use text to highlight the essential information and share the rest orally to keep an HCP focused and engaged. Interactivity is a must Make your eDetailer as interactive as possible. Content doesn’t attract attention without an engaging presentation. Create immersive experiences for HCPs by adding transitions between slides, animating objects, and hiding interesting facts in pop-ups and drop-down lists. Make it as intuitive as possible Create layouts that are easy to understand to make HCPs easily perceive eDetailing content at first glance and stick to the principle of simplicity. If you don’t know how to make your eDetailers simpler and more intuitive, show your eDetailer to your team before engaging with HCPs. After engaging with HCPs, ask for detailed feedback and track their interactions within each slide. Read how we assisted a top 50 pharmaceutical enterprise in transforming complicated descriptive materials into an easy-to-understand interactive e-detailer. Download a concise case study to learn e-detailing best practices in more detail, present your pharmaceutical product at its best, and successfully engage with HCPs. Professional E-Detailers for a Pharmaceutical Company Made Easy Want to create next-generation interactive presentations with top-notch design and tailor them to the current needs of HCPs in personalized customer journeys? eWizard, a content experience platform, enables top pharma and life sciences companies with everything needed to leverage pharmaceutical detailing in omnichannel marketing: Intuitive Creation. Thanks to a diverse collection of pre-built templates and easy-to-use tools, pharmaceutical representatives can create interactive e-detailers without professional coding and design skills; Accelerated MLR Review and Approval. Powered by modular content, eWizard allows your company to reuse pre-approved content blocks and tremendously accelerate the medical, legal, and regulatory process for e-detailing; Integration for any Purpose and KPI Tracking. Your team can integrate eWizard with any popular system or platform to thoroughly analyze the effectiveness of e-detailing by tracking HCP behavior on an advanced level. Please complete the form below, and our specialists will get to you shortly with a professional e-detailing consultation.
How to Pivot your Modular Content Strategy on the Fly Posted on May 9, 2023November 15, 2024 by Andrii Nikulin Pharma has to deal with complex workflows — that’s why it is so important to improve the ways content is developed. Again and again, it proves beneficial to set up a single workflow, where all assets are perfectly aligned, approved, and can be used repeatedly across multiple channels. The realities require a new method of disseminating messages and materials in the digital environment This case study presents an approach that helps to pivot an omnichannel with a modular content strategy on the fly, while it is running and operational, and create the highest impact to the customers with 100% flexible content. You can access the сase study using the form below.
How omnichannel technologies increase patient adherence Posted on April 17, 2023November 15, 2024 by Andrii Nikulin Patient adherence is essential, not only for marketing purposes. It is necessary for efficient treatment as the more the patient trusts and relies on the doctor, the better the recovery. Failed adherence leads to substantial worsening of disease, death, and increased healthcare costs. This case study is dedicated to improving communication between HCPs and patients and using digital adherence technologies as an omnichannel approach. We will cover the topics of diligent patients’ culture and build a ladder of patient success in 6 short but meaningful steps. Customer and project info Our customer is one of the top 50 pharma companies worldwide. The pharma giant became interested in building a proper customer journey for their patients with chronic diseases. So, they relied on our assistance and technical expertise. Case The main priorities were to identify barriers to timely therapy and define techniques to engage patients to finish the treatment course. The strategy includes increasing the number of communication channels and developing a customer journey campaign. In the end, the customer would like a comprehensive IT infrastructure with integrated additional marketing communications services. Solution The primary step of the solution was implementing a patient-centric approach to all stages of the customer journey. We analyzed patient behavior scenarios to understand the patient’s needs, behavioral trends, and engagement barriers. After that, it was necessary to determine the marketing automation software and integrate it with previously defined communication channels. Gathering patients’ data was the key to building an omnichannel patient-centric marketing campaign and creating adherence. Results Patient adherence has significantly increased within the first five months of the marketing campaign for every targeted audience. The number of bulk mailings decreased by 1.5 times. The omnichannel patient engagement campaign performed much better than the previous approach. Learn more about patient adherence technology solutions for life sciences — fill out the form below to get a case study.
eLearning Application for Pharmacists with Interactive Content Posted on April 10, 2023November 15, 2024 by Andrii Nikulin Client Industry: Pharmaceutical Location: Denmark Size: 99.000 employees (117.00 now) Company Description A health care company that specializes in medical devices, diagnostics, branded generic medicines and nutritional products. The company focuses on a wide array of medical and pharma solutions: from chronic pain and movement disorders to connecting patients to doctors with real-time monitoring information and testing half the world’s blood donations to ensure a healthy supply. Project Details People: 8 Timeline: 1300 hours and 4 months Technologies: Angular (PWA) Firebase Swift Java HTML5 eWizard Photoshop Git Visualforce Studio Gigya Project Overview The goal of the request was to create an educational app for pharmacists with the help of interactive visual materials. The educational point was to provide the Pharmacists with more detailed information about strategic marketing in the pharmaceutical business. For these purposes, we decided to create two native mobile apps and interactive educational materials (which were the basis for Survey functionality in eWizard). Another critical step was to create an administrative portal where the admin could follow the analytics of app usage and upload respective courses to respective countries. Why Viseven? Cooperation started in 2010 and the long story of relationships resulted in many services in various domains, such as Mobile Development, CRM and CLM solutions, Web development, etc. The development of the “Pharmacist Guide” started in 2015 and, since 2020 project is in the long-term support stage. Solution To fulfill customer’s request appropriately, we enumerated the stages of the project: concept creation; design; development; testing; UAT; go-live; support; customization (new modules); localization of app and modules. The application should allow pharmacists to log in via a specific code. Inside, they should be able to find the courses with interactive materials to see, listen to, and answer the survey questions to see if the information is understood. The users in one region were defined in the ranking list to add some gamification. From an admin perspective, it was possible to create countries, upload courses and materials and also follow the analytics. To fulfill the high-quality standards, software quality and security followed Guidelines and Security Check. To follow these guidelines, Viseven and client constantly communicated via email and Google Meet with the following regular activities: General Stand-Up with Customer Regular Status call (weekly) Customer demo after each iteration Requirements Grooming sessions. Results Viseven managed to fulfill the request and met time and budget estimates. The product was launched in approximately 15 countries with around 5000 users involved. Although all further statistic is not available, as the Customer manages it, Client was satisfied with the outcome of the collaboration, especially by design and quality of the application. A client requested some customized and localized modules to add to the project scope after release as a separate initiative. Download a case study and learn more by filling out the contact form below.
How to Save Money Producing More Content? Posted on April 7, 2023November 15, 2024 by Andrii Nikulin [wpb-pcf-button id=”48971″ text=”DOWNLOAD” btn_size=”large” class=”btn-blue-green btn-wpb-pcf-center” width=”623px”] Digital transformation is no longer just a buzz word, it become an important strategic imperative in most of Global Pharma Companies. The ultimate goal of Pharma & Life science digital transformation is to improve efficiency, productivity, and patient outcomes as well as educate and engage the target audience through the use of advanced technologies and data analytics Client: The multinational pharmaceutical company, listed in Top-50 global pharmaceutical companies. Project Coverage: Global Challenges: increasing content demand, high cost of content production by Creative agencies; budget increase didn’t follow the demand increase pace; regions are siloed from each other as well as from the global office – no unified ecosystem for content; management – multiple custom platforms in different regions; decentralized content creation, lack global-to-local reuse; need for global messages & visual consistency. Results: A Digital Content Factory (DCF) has been developed for end-to-end content production. From 2020 to 2022, the demand for content in DCF increased by +49% (ready assets), while the cost decreased by -17%. For some asset types, the cost decreased by almost -60% in three years. The significant cost decrease was generated by the massive growth of local content reuse. In 2022, content update requests increased by +99% compared to 2020. On average, we achieved a -37% TTM acceleration for key content formats. Download the full case study document to learn more about the solution that allows us to achieve such great results.
